Streetbeat News

Stock Prices

SPY

USA Wholesale Inventories for May remained unchanged at 0.0%, beating the estimated -0.1% and matching the prior figure of -0.1%.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 2:00 pm

INTA

Analysts have provided bullish ratings for Intapp (NASDAQ:INTA) within the last quarter, with an average price target of $48.5, a high of $55.00, and a low of $42.00. The average price target has increased by 26.66% over the past month.

Portfolio Pulse from Benzinga Insights

July 10, 2023 | 2:00 pm

BYRN

Byrna Technologies (NASDAQ:BYRN) is set to release its latest quarterly earnings report on Tuesday, 2023-07-11. Analysts estimate an earnings per share (EPS) of $0.01. The company's past performance shows a mixed trend of beating and missing EPS estimates, with varying impacts on the share price. The stock is currently trading at $4.91, down 35.38% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

July 10, 2023 | 2:00 pm

PLSH

Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) is set to acquire eight retail locations in Tampa, Florida, which offer Kava, Kratom, VAPE and CBD products. The acquisition, which includes inventory, equipment, recipes, distribution facilities and a warehouse, generated $2.9 million of annual revenues for the fiscal year ended December 31, 2022. The purchase will be made through the issuance of approximately 85,000 shares of a new class of convertible preferred stock, convertible into approximately 8.5 million shares of common stock.

Portfolio Pulse from Vuk Zdinjak

July 10, 2023 | 2:00 pm

NVS

Novartis AG (NYSE:NVS) has received an unfavorable decision from the U.S. District Court for the District of Delaware regarding the validity of a patent covering its heart failure treatment Entresto. Despite this, Novartis maintains its outlook for 2023 and its mid-term outlook of 4% sales growth between 2022-2027. The company plans to appeal the decision. Novartis' shares are up 2.07% at $96.68.

Portfolio Pulse from Vandana Singh

July 10, 2023 | 1:58 pm

TIVC

Tivic Health Systems Inc's stock is down by 46% after the company priced its public offering of 32.5 million shares at $0.055 per share. The offering is expected to generate approximately $1.8 million in gross proceeds. The company intends to use the net proceeds for general corporate purposes and working capital.

Portfolio Pulse from Henry Khederian

July 10, 2023 | 1:55 pm

NVO

The European Medicines Agency is investigating Novo Nordisk's weight-loss medications, including Saxenda, Ozempic, and Wegovy, due to reports of suicidal risks. The investigation was initiated after the Icelandic Medicines Agency reported two cases of suicidal thoughts linked to these drugs. Despite the investigation, Novo Nordisk's shares are slightly up.

Portfolio Pulse from Vandana Singh

July 10, 2023 | 1:54 pm

JNJ

NBTX

Nanobiotix (NBTX) has entered into a global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV, a unit of Johnson & Johnson (JNJ), for the investigational radioenhancer NBTXR3. Janssen will pay $60 million in upfront fees and funding for an exclusive worldwide license. The agreement also includes potential milestone payments of up to $650 million for five new indications that Janssen may develop, and up to $220 million per indication that Nanobiotix may develop in alignment with Janssen.

Portfolio Pulse from Vandana Singh

July 10, 2023 | 1:52 pm

META

Meta Platforms Inc.'s Threads platform has reached 100 million users, leading to an increase in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 1:40 pm

NTRS

UBS analyst Brennan Hawken has downgraded Northern Trust (NASDAQ:NTRS) from Buy to Neutral and lowered the price target from $100 to $80.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 1:36 pm